These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 25525303

  • 1. GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis.
    Zhang H, Wang W, Fang H, Yang Y, Li X, He J, Jiang X, Wang W, Liu S, Hu J, Liu A, Dahmen U, Dirsch O.
    Mediators Inflamm; 2014; 2014():629507. PubMed ID: 25525303
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX, Lu L, Wu ZS, Pu LY, Sun BC, Wang XH.
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [Abstract] [Full Text] [Related]

  • 3. Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
    Ren F, Zhou L, Zhang X, Wen T, Shi H, Xie B, Li Z, Chen D, Wang Z, Duan Z.
    Inflammation; 2015 Jun; 38(3):1151-65. PubMed ID: 25630719
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ferulic acid positively modulates the inflammatory response to septic liver injury through the GSK-3β/NF-κB/CREB pathway.
    Cao L, Li Z, Yang Z, Wang M, Zhang W, Ren Y, Li L, Hu J, Sun Z, Nie S.
    Life Sci; 2021 Jul 15; 277():119584. PubMed ID: 33961853
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
    Chen H, Yang S, Yang Z, Ma L, Jiang D, Mao J, Jiao B, Cai Z.
    J Cell Biochem; 2007 Dec 01; 102(5):1281-9. PubMed ID: 17427960
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β.
    Liu T, Fang Y, Liu S, Yu X, Zhang H, Liang M, Ding X.
    Free Radic Biol Med; 2015 Apr 01; 81():170-82. PubMed ID: 25451640
    [Abstract] [Full Text] [Related]

  • 12. GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.
    Li B, Zhang C, He F, Liu W, Yang Y, Liu H, Liu X, Wang J, Zhang L, Deng B, Gao F, Cui J, Liu C, Cai J.
    Cell Physiol Biochem; 2013 Apr 01; 32(6):1720-8. PubMed ID: 24356466
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
    Lohning A, Kidachi Y, Kamiie K, Sasaki K, Ryoyama K, Yamaguchi H.
    Eur J Med Chem; 2021 Apr 15; 216():113250. PubMed ID: 33691258
    [Abstract] [Full Text] [Related]

  • 15. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
    Hummler SC, Rong M, Chen S, Hehre D, Alapati D, Wu S.
    Am J Respir Cell Mol Biol; 2013 May 15; 48(5):578-88. PubMed ID: 23328640
    [Abstract] [Full Text] [Related]

  • 16. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
    Kai JI, Huang WC, Tsai CC, Chang WT, Chen CL, Lin CF.
    J Cell Biochem; 2010 Dec 15; 111(6):1522-30. PubMed ID: 20872791
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
    Kim SD, Yang SI, Kim HC, Shin CY, Ko KH.
    Brain Res; 2007 Dec 15; 1186():12-20. PubMed ID: 17996850
    [Abstract] [Full Text] [Related]

  • 18. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J.
    Cardiovasc Res; 2007 Jan 01; 73(1):130-42. PubMed ID: 17137568
    [Abstract] [Full Text] [Related]

  • 19. GSK-3β inhibition protects the rat heart from the lipopolysaccharide-induced inflammation injury via suppressing FOXO3A activity.
    Li Z, Zhu H, Liu C, Wang Y, Wang D, Liu H, Cao W, Hu Y, Lin Q, Tong C, Lu M, Sachinidis A, Li L, Peng L.
    J Cell Mol Med; 2019 Nov 01; 23(11):7796-7809. PubMed ID: 31503410
    [Abstract] [Full Text] [Related]

  • 20. Inhibiting glycogen synthase kinase 3beta in sepsis.
    Dugo L, Collin M, Allen DA, Patel NS, Bauer I, Mervaala E, Louhelainen M, Foster SJ, Yaqoob MM, Thiemermann C.
    Novartis Found Symp; 2007 Nov 01; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.